alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnstock, G; Gur, S; Hellstrom, WJ; Knight, GE; Sikka, SC | 1 |
| Matsumoto, T; Tostes, RC; Webb, RC | 1 |
| Badia, A; Giraldo, J; Goñalons, E; Guitart, M; Jiménez, M | 1 |
| Brunkwall, J; Edvinsson, L; Erilnge, D; Lind, H | 1 |
| Fernández, O; Osuna, A; Vargas, F; Wangensteen, R | 1 |
| Fink, GD; Galligan, JJ; Hess, MC; Miller, SB | 1 |
6 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and Hypertension
| Article | Year |
|---|---|
Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
Topics: Adenosine Triphosphate; Animals; Electric Stimulation; Enzyme Inhibitors; Hypertension; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Phenylephrine; Piperazines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Purines; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X3; Sildenafil Citrate; Sulfones; Vas Deferens; Vasodilator Agents | 2010 |
Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Arteries; Basilar Artery; Desoxycorticosterone; Dinucleoside Phosphates; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Hypertension; Male; Mesenteric Arteries; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Sodium Chloride, Dietary; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Changes in electrophysiological properties in the prostatic portion of vas deferens from spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Electrophysiology; Hypertension; Male; Prostate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vas Deferens | 2002 |
Attenuation of contractile responses to sympathetic co-transmitters in veins from subjects with essential hypertension.
Topics: Acetylcholine; Adenosine Triphosphate; Aged; Aged, 80 and over; Female; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents; Veins | 1997 |
Renal vascular reactivity to P(2)-purinoceptor activation in spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Hypertension; In Vitro Techniques; Kidney; Male; Perfusion; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P2; Thionucleotides; Vascular Resistance; Vasoconstriction; Vasodilation | 2000 |
Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats.
Topics: Adenosine Triphosphate; Algorithms; Animals; Desoxycorticosterone; Hypertension; Immunohistochemistry; Male; Mesenteric Arteries; Mesenteric Veins; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Uridine Triphosphate; Vasoconstriction | 2001 |